Marshall Wace LLP Purchases Shares of 13,282 Henry Schein, Inc. (NASDAQ:HSIC)

Marshall Wace LLP acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 13,282 shares of the company’s stock, valued at approximately $851,000.

Several other institutional investors also recently modified their holdings of HSIC. Bank of Montreal Can increased its stake in shares of Henry Schein by 6.7% in the second quarter. Bank of Montreal Can now owns 152,798 shares of the company’s stock worth $10,320,000 after buying an additional 9,596 shares during the period. Magnetar Financial LLC grew its holdings in Henry Schein by 32.1% in the 2nd quarter. Magnetar Financial LLC now owns 510,610 shares of the company’s stock worth $32,730,000 after acquiring an additional 124,152 shares during the last quarter. Public Sector Pension Investment Board increased its position in shares of Henry Schein by 64.9% in the second quarter. Public Sector Pension Investment Board now owns 4,936 shares of the company’s stock valued at $316,000 after acquiring an additional 1,942 shares during the period. ProShare Advisors LLC raised its stake in shares of Henry Schein by 6.6% during the second quarter. ProShare Advisors LLC now owns 18,860 shares of the company’s stock valued at $1,209,000 after acquiring an additional 1,165 shares during the last quarter. Finally, Summit Trail Advisors LLC boosted its holdings in shares of Henry Schein by 20.0% during the second quarter. Summit Trail Advisors LLC now owns 10,271 shares of the company’s stock worth $658,000 after purchasing an additional 1,709 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Trading Up 1.0 %

Henry Schein stock opened at $69.99 on Wednesday. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The business’s fifty day moving average is $70.06 and its 200 day moving average is $70.02. The stock has a market capitalization of $8.96 billion, a PE ratio of 23.65, a price-to-earnings-growth ratio of 2.01 and a beta of 0.86. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The company had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. Henry Schein’s revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 earnings per share. On average, sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on HSIC shares. JPMorgan Chase & Co. reduced their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Evercore ISI lifted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday. Barrington Research restated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a report on Friday, September 20th. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Finally, Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $77.50.

Insider Transactions at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.